Own-brand buys and No7 skincare boosts sales for Boots
The pharmacy and retail chain said its own ranges have been flying off the shelves as consumers hunt down value.
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Boots has revealed a surge in online shoppers and people opting for own-brand labels has driven up sales over the latest quarter.
The pharmacy and retail chain said its own ranges have been flying off the shelves as consumers hunt down value.
It came as its US owner, Walgreens Boots Alliance (WBA), revealed its net quarterly profit more than halved as demand for Covid vaccines and testing declined.
Retail sales across Boots jumped by 13.4% in the three months to the end of May, compared to the same period last year.
It was driven up by a boost in online shoppers with sales on its digital platform surging by a quarter over the latest period.
Boots said its “Everyday” essentials label, which includes 60 toiletries and personal care products sold for less than £1.50, saw volume growth of 40% – meaning more products were sold.
The company said it reflects people opting for more affordable products, amid a squeeze on households’ disposable incomes.
More consumers are shopping at Boots more often, the chain said. It marks a shift from other major personal care retailers like Unilever which have seen sales boosted by higher prices rather than people buying more.
Beauty products, especially skincare, were best sellers over the latest period with sales up 18% year on year, and May recording the biggest week for the category outside of Christmas.
Its in-house brand No7 also sold well during the quarter, as well as suncare range Soltan amid seasonally warmer weather.
The group’s pharmacy arm saw sales grow by 5.7%, driven by hay fever products and over-the-counter medication, including the launch of its erectile dysfunction range, Eroxon.
It comes as owner WBA last year pulled its plans to sell the UK retailer, after receiving a number of takeover approaches including one valuing it at about £5 billion.
The Walgreens merger deal for Boots in 2014 valued the firm at about £9 billion at the time.
Seb James, the managing director of Boots UK and ROI, said: “Our focus on offering our customers the best in healthcare and beauty, together with a continued commitment to great value, has been well received, and it is lovely to see more people choosing to shop with Boots.
“It is particularly pleasing to see our own brands proving popular, including an exceptional No7 performance.”